普洛药业 (000739.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

17.5x

EV/EBITDA

13.7x

Market Cap

CNY 22.83B

MomentumView details →

1D Return

−4.87%

YTD Return

+37.37%

RSI (14)

57.9

ValuationView details →

P/E (Fwd)

17.5x

EV/EBITDA

13.7x

Market Cap

CNY 22.83B

RSI (14)

57.9

MomentumView details →

1D Return

−4.87%

YTD Return

+37.37%

ProfitabilityView details →

Gross Margin

27.79%

Net Margin

9.38%

EBITDA Margin

18.34%

ROE (TTM)

13.58%

ROA (TTM)

7.27%

Asset Turnover

0.77x

GrowthView details →

Revenue YoY

−17.77%

EPS YoY

−12.99%

FCF YoY

+89.52%

Revenue CAGR 3Y

−2.47%

EPS CAGR 3Y

−2.86%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.24

EPS Surprise

−17.24%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.34

Avg Surprise (4Q)

−17.24%

Rev Surprise

−0.96%

Capital & dividendView details →

Debt/Equity

0.24x

Current Ratio

1.55x

Quick Ratio

1.28x

Div Yield

2.62%

Div Rate

CNY 0.59

Div Growth 1Y

−66.21%

Financials snapshotView financials →

Revenue (TTM)

9.50B

Net Income (TTM)

891.15M

Op. CF (TTM)

1.36B

Next earningsOct 16, 2026 →

Latest newsMore news →

Puluo Pharmaceutical and others jointly established a new biotechnology company, Zhejiang Ante Yutai Biotechnology Co., Ltd., with registered capital of 10 million yuan.13h ago

Apeloa Pharmaceutical announced it will provide financial assistance of 255 million yuan to its subsidiary Zhejiang Ante Yutai Biotechnology Co., Ltd., with related party Hengdian Co., Ltd. contributing 245 million yuan, at an annualized interest rate of 3% for up to three years.1d ago

Similar companies

博源化工000683.SZ 当升科技300073.SZ 博杰股份002975.SZ 中国重汽000951.SZ 赛微电子300456.SZ 托伦斯301583.SZ Find similar companies →

Latest newsMore news →

Puluo Pharmaceutical and others jointly established a new biotechnology company, Zhejiang Ante Yutai Biotechnology Co., Ltd., with registered capital of 10 million yuan.13h ago Apeloa Pharmaceutical announced it will provide financial assistance of 255 million yuan to its subsidiary Zhejiang Ante Yutai Biotechnology Co., Ltd., with related party Hengdian Co., Ltd. contributing 245 million yuan, at an annualized interest rate of 3% for up to three years.1d ago As of August 31, 2026, Zhejiang Apeloa Pharmaceutical Co., Ltd. had repurchased 5.4101 million shares for approximately 99.99 million yuan under its ongoing buyback program.3d ago